DIA
SCMP

Dana Investment Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Dana Investment Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-185,710
Closed -$3.33M – 303
2017
Q4 		$3.33M Sell
185,710
-15,828
-8% -$195K 0.15% 106
2017
Q3 		$2.38M Buy
201,538
+14,089
+8% +$158K 0.11% 151
2017
Q2 		$1.97M Buy
187,449
+27,294
+17% +$278K 0.09% 187
2017
Q1 		$1.76M Buy
160,155
+21,434
+15% +$249K 0.08% 197
2016
Q4 		$1.88M Buy
+138,721
New +$1.94M 0.09% 189

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Dana Investment Advisors's SCMP Position: Q1 2018 in Review

Dana Investment Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 185,710 shares — an estimated $3.33M sold.

Dana Investment Advisors first reported a position in SCMP in Q4 2016 and held it in 5 quarters. The position peaked at $3.33M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Dana Investment Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Dana Investment Advisors sold 185,710 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3.33M.
  • Dana Investment Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
  • Dana Investment Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $3.33M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Dana Investment Advisors's 13F filing for Q1 2018, filed 15 May 2018.